Serotonin and the peripheral circulation

Area of Science:

• Cardiovascular Biology
• Platelet Physiology
• Vascular Pharmacology

Background:

• Platelets play a role in atherosclerosis and ischemic syndromes.
• Serotonin released by platelets contributes to ischemia.
• Serotonin constricts arteries via the 5-HT2 receptor, particularly in collateral vessels.

Purpose of the Study:

• To investigate the role of platelet-released serotonin in limb ischemia.
• To evaluate the efficacy of serotonin receptor antagonists in reversing serotonin-induced vasoconstriction.
• To explore the combined effects of blocking serotonin and thromboxane pathways.

Main Methods:

• Inducing platelet activation and endothelial damage in rabbit collateral limb vessels via mechanical abrasion.
• Administering ketanserin (a 5-HT2 receptor antagonist) to assess its effect on collateral vessel response.
• Investigating the impact of simultaneous blockade of serotonin and thromboxane pathways.

Main Results:

• Platelet activation released vasoactive quantities of serotonin.
• Ketanserin partially reversed the vasoconstrictive effects of serotonin on collateral vessels.
• Simultaneous blockade of serotonin and thromboxane demonstrated a greater effect than blocking either agent alone.

Conclusions:

• Platelet-derived serotonin significantly contributes to vasoconstriction in collateral limb arteries.
• Targeting the 5-HT2 serotonin receptor with antagonists like ketanserin can mitigate these effects.
• Combined blockade of serotonin and thromboxane pathways offers a promising therapeutic strategy for ischemic syndromes.